<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="64949">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02260388</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001500</org_study_id>
    <secondary_id>PCORI-1306-02496</secondary_id>
    <nct_id>NCT02260388</nct_id>
  </id_info>
  <brief_title>Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations</brief_title>
  <acronym>PAIN-CONTRoLS</acronym>
  <official_title>Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this large comparative effectiveness study led by Richard J. Barohn, MD, of
      the University of Kansas Medical Center, is to learn about the safety and effectiveness of
      nortriptyline, duloxetine, pregabalin and mexiletine in treating cryptogenic sensory
      polyneuropathy (CSPN).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this research project is to find the best drug for the treatment of pain in
      patients with CSPN. While the pharmaceutical industry has focused attention on drugs for
      treating diabetic sensory neuropathy (DSPN), and two drugs are now FDA approved, there have
      not been any prospective trials in CSPN. And, because there are no studies with CSPN
      patients, insurance carriers often reject authorizing prescriptions for some drugs for
      patients with CSPN.

      There are four drugs that will be tested in this study: nortriptyline, duloxetine,
      pregabalin and mexiletine. These drugs are not approved by the FDA for the treatment of CSPN
      and are considered &quot;investigational&quot; in this study.

      There are two periods in this study: Screening/Baseline and Study Drug. During the
      Screening/Baseline period the researchers will determine eligibility for potential subjects.
      During the second period, eligible patients who consented to participate will take the study
      drug. Participants will be randomized to receive one of the four drugs in this study.
      Participants will know which drug they are taking. Participants will not be allowed to
      switch groups and receive a different drug during the study.

      This study uses an adaptive study design. This means the study can enroll less participants
      and provide better conclusions. The study design allows the researchers the ability to make
      changes to the approach of the study or to stop the study early if there are strong results.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in patient-reported pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patients will complete a Likert-type scale for pain at each visit, the Patient Reported Outcome Measurement Information System (PROMIS) 6 item pain interference scale. Final measurement is based on the change in pain score at the end of 12 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients who discontinue treatment</measure>
    <time_frame>Up to 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in general health and well being</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change will be measured using the Short Form Health Survey (SF-12) questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain interference</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measure of how pain and how it may interfere with multiple aspects of each participants life. Changes will be measured using the National Institutes of Health (NIH) Pain Interference Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fatigue</measure>
    <time_frame>12 Weeks</time_frame>
    <description>Participants will complete NIH Fatigue Interference Scale at study visits. Responses will measure change in how often, how long, how intense a participant's fatigue is and how fatigue affects their life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Sleep</measure>
    <time_frame>12 weeks</time_frame>
    <description>Participants will complete NIH Sleep Disturbance Scale at study visits. Scale measures quality and length of sleep. Outcome measured by change in scores from baseline visit to end of study/week 12 visit.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cryptogenic Sensory Polyneuropathy</condition>
  <arm_group>
    <arm_group_label>Nortriptyline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nortriptyline - 25 mg daily for 1 week at bedtime, then 50 mg daily at bedtime for 1 week, then 75 mg daily at bedtime for the remainder of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Duloxetine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Duloxetine - 20 mg daily for 1 week, then 40 mg daily for 1 week, then 60 mg daily for the remainder of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pregabalin - 100 mg at bedtime for 1 week, then 100 mg 2 times per day for 1 week, then 100 mg 3 times per day for the remainder of the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mexiletine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mexiletine - 200 mg at bedtime for 1 week, then 200 mg 2 times per day for 1 week, then 200 mg 3 times per day for the remainder of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nortriptyline</intervention_name>
    <arm_group_label>Nortriptyline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <arm_group_label>Duloxetine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <arm_group_label>Pregabalin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mexiletine</intervention_name>
    <arm_group_label>Mexiletine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of cryptogenic sensory polyneuropathy.

          -  Likert Pain Score of greater than or equal to 4.

          -  Must not currently be on nortriptyline, duloxetine, pregabalin or mexiletine or
             similar class of medication for at least 7 days from baseline study visit.

        Exclusion Criteria:

          -  Any medical condition or current medication that would prevent them from taking
             either nortriptyline, duloxetine, pregabalin or mexiletine.

          -  Unable to give consent.

          -  Unable or not willing to comply with the study.

          -  Other causes for polyneuropathy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Barohn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen Walsh</last_name>
    <phone>(913)588-0645</phone>
    <email>mwalsh2@kumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gale Kittle</last_name>
      <phone>602-406-6262</phone>
      <email>Gale.Kittle@DignityHealth.org</email>
    </contact>
    <investigator>
      <last_name>Shafeeq Ladha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Neurological Associates</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Allred, PT DPT</last_name>
      <phone>424-315-2694</phone>
      <email>Peggy.allred@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Richard Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Irvine Medical Center, ALS &amp; Neuromuscular Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Y-Nhy Duong</last_name>
      <phone>415-502-2128</phone>
      <email>nhy-y.duong@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Ralph, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Denver Anschutz Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Kling</last_name>
      <phone>303-724-6247</phone>
      <email>Brittany.kling@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Dianna Quan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado Springs Neurological Associates</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jodi Ventimiglia</last_name>
      <email>jventimiglia@csneuro.com</email>
    </contact>
    <investigator>
      <last_name>Laurence Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Science Center - Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasmeen Shabbir</last_name>
      <phone>904-244-9814</phone>
      <email>yasmeen.shabbir@jax.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Pulley, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Quesada</last_name>
      <phone>305-243-7424</phone>
      <email>mquesada2@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Khema Sharma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurological Services of Orlando Research</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Cabrera</last_name>
      <phone>407-240-1762</phone>
      <email>michele.nsor@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Navin Verma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Harvey</last_name>
      <phone>813-974-9413</phone>
      <email>bharvey1@health.usf.edu</email>
    </contact>
    <investigator>
      <last_name>Tuan Vu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Guingrich</last_name>
      <phone>317-963-7382</phone>
      <email>sguingri@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Pascuzzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center - Des Moines</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Inman</last_name>
      <phone>515-238-7361</phone>
      <email>cinman@mercydesmoines.org</email>
    </contact>
    <investigator>
      <last_name>Michael Jacoby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hutchinson Clinic, PA</name>
      <address>
        <city>Hutchinson</city>
        <state>Kansas</state>
        <zip>67502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaun Morales</last_name>
      <email>MoralesJ@hutchclinic.com</email>
    </contact>
    <investigator>
      <last_name>William Mallonee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Liu</last_name>
      <phone>913-945-9932</phone>
      <email>tliu@kumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norton Neurology Services</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Couch</last_name>
      <phone>502-629-3376</phone>
      <email>elizabeth.couch@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Mark Bazant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Douglass</last_name>
      <phone>617-525-6497</phone>
      <email>PDOUGLASS1@PARTNERS.ORG</email>
    </contact>
    <investigator>
      <last_name>Mohammad Kian Salajegheh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Beck</last_name>
      <phone>734-647-9224</phone>
      <email>ktbeck@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Sindhu Ramchandren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health System</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49525</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsten Lubben</last_name>
      <phone>616-218-0311</phone>
      <email>Kirstin.lubben@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Paul Twydell, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hilbert, MS</last_name>
      <phone>612-624-5978</phone>
      <email>hilbe010@umn.edu</email>
    </contact>
    <investigator>
      <last_name>David Walk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Hamtil</last_name>
      <phone>314-302-6426</phone>
      <email>hamtilal@slu.edu</email>
    </contact>
    <investigator>
      <last_name>Ghazala Hayat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Heimes</last_name>
      <phone>402-552-6246</phone>
      <email>deb.heimes@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Pariwat Thaisetthawatkul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Buffalo School of Medicine and Biomedical Sciences</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Patrick</last_name>
      <phone>716-859-7510</phone>
      <email>kpatrick@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Gil Wolfe, MD, FAAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Scoon, MPH MD</last_name>
      <phone>212-305-6035</phone>
      <email>js4462@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Brannagan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Beth Israel</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Ripps, RN</last_name>
      <email>eripps@chpnet.org</email>
    </contact>
    <investigator>
      <last_name>Stephen Scelsa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Health</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alecia Boehl</last_name>
      <phone>513-558-0039</phone>
      <email>boehlaa@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Hani Kushlaf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irys Caristo</last_name>
      <phone>216-444-0173</phone>
      <email>CARISTI@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Yuebing Li, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filiz Muharrem</last_name>
      <phone>614-688-7837</phone>
      <email>filiz.muharrem@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Stanley Iyadurai, MSc, PhD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Dimitrova, PhD</last_name>
      <phone>503-494-7269</phone>
      <email>dimitrov@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Chafic Karam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Runk</last_name>
      <phone>717-531-0003</phone>
      <email>hrunk@hmc.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anne Morris</last_name>
      <phone>717-531-0003</phone>
      <email>amorris2@hmc.psu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Wicklund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Neuromuscular Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ameel Husseini</last_name>
      <phone>512-920-0140</phone>
      <email>ameelhusseini@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yessar Hussain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sara Austin, MD, PA</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Seton Brain and Spine Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krishna Saini</last_name>
      <phone>513-324-8300</phone>
      <email>kmSaini@seton.org</email>
    </contact>
    <investigator>
      <last_name>Sara Austin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Neurology</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Morgan</last_name>
      <phone>214-279-0310</phone>
      <email>tmorgan@texasneurology.com</email>
    </contact>
    <investigator>
      <last_name>Daragh Heitzman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nina Gorham</last_name>
      <phone>214-648-0462</phone>
      <email>Nina.Gorham@UTSouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Jaya Trivedi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houton</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Wilkerson</last_name>
      <phone>713-500-6785</phone>
      <email>Carla.D.Wilkerson@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Suur Biliciler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurology Clinic of Central Texas</name>
      <address>
        <city>New Braunfels</city>
        <state>Texas</state>
        <zip>78132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bill Davis, MD</last_name>
      <phone>830-606-9142</phone>
      <email>billdel@satx.rr.com</email>
    </contact>
    <investigator>
      <last_name>Bill Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center in San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Kittrell, RN MSN CCRC</last_name>
      <phone>210-450-0524</phone>
      <email>kittrellp@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Alejandro Tobon-Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Stonebraker</last_name>
      <phone>801-585-2741</phone>
      <email>angela.stonebraker@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Gordon Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Lucy</last_name>
      <phone>802-733-5779</phone>
      <email>Shannon.Lucy@med.uvm.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Hehir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amruta Joshi</last_name>
      <phone>434-982-0293</phone>
      <email>ASJ6N@hscmail.mcc.virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Ted Burns, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Ng</last_name>
      <email>Eduardo.Ng@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Vera Bril, MD, FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 7, 2017</lastchanged_date>
  <firstreceived_date>October 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CSPN</keyword>
  <keyword>neuropathy</keyword>
  <keyword>pain</keyword>
  <keyword>pain management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Polyneuropathies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Nortriptyline</mesh_term>
    <mesh_term>Mexiletine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
